{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicuhp4zwy22p4wokbb46wpe53uvbiawdwzaxjmrrttfxnmolfvh6a",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mehd2wbzhst2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/02/09/novo-hims-obesity-patents-compounding-lilly-takeda/?utm_campaign=rss",
  "publishedAt": "2026-02-09T14:36:11.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned…",
  "title": "STAT+: Pharmalittle: We’re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and more",
  "updatedAt": "2026-02-09T16:31:19.000Z"
}